AtaiBeckley Inc. 13D

Apeiron, Presight affiliates, and Christian Angermayer hold about 15.4% of AtaiBeckley and have agreed via support agreements to vote their shares in favor of Eli Lilly’s merger, signaling support for the takeout rather than activism.

Apeiron Investment Group Ltd., affiliated Presight entities, Fabian Hansen, and Christian Angermayer report beneficial ownership of 56,812,134 AtaiBeckley Inc. common shares, representing approximately 15.4% of outstanding voting rights, with this Amendment No. 4 reflecting their entry into voting and support agreements obligating them to vote their stake in favor of Eli Lilly’s agreed merger with AtaiBeckley, refrain from transferring their shares, and abide by related restrictions, indicating support for the announced sale rather than new activist initiatives.

Filing Facts

CIK

2081043

Ticker

ATAI

Form

13D

Source Type

fda

Accession

0001193125-26-308002

Alert Tier

7